Skip to main content

JPMORGAN CHASE & CO

Position in TRVI — Trevi Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in TRVI

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$842,626
+$98,001 QoQ
Shares Held
70,631
+18.8% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
14 quarters on record
Voting authority Sole 15.793348529682433.ToString("F0")% Shared 0.ToString("F0")% None 84.20665147031757.ToString("F0")%

Common Shares in TRVI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,578,634,665 across 404 Biotechnology names. TRVI ranks #174 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRVI

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $842,626 70,631
2025-12-31 $744,625 59,475
2025-09-30 $538,157 58,815
2025-06-30 $297,250 54,342
2025-03-31 $399,112 63,452
2024-12-31 $913,253 221,664
2024-09-30 $335,726 100,517
2024-06-30 $93,422 31,350
2024-03-31 $87,845 25,463
2023-12-31 $36,157 26,983
2023-09-30 $58,827 26,985
2023-06-30 $79,285 33,174
2020-09-30 $12 3
2020-06-30 $19 3